Giant cell arteritis - 3D vessel wall imaging with blood suppression using 3T MRI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00009518

Enrollment

Registered

2015-10-13

Start date

2015-10-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M31.6

Interventions

Group 1: During the MRI examination both the dtandard MRI sequences as well as the new MRI 3D sequence will be done. Afterwards both sequences can be compared. There will be no "2. Arm" to compare tho

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. clinical indication for a MRI. 2. Patient is mature and of full age. 3. Exclusion of pregnancy through anamnesis or in cases of uncertainty through testing.

Exclusion criteria

Exclusion criteria: There is a contraindication versus a MRI examination.

Design outcomes

Primary

Measure	Time frame
We want to prove if a new 3T sequence (T1 SPACE with fat- und blood suppression) is better showing the extracraniel vessels then the standard sequences.	—

Secondary

Measure	Time frame
Comparison of the new and old sequences evaluating extracranial vessels.	—

Countries

Germany

Contacts

Public ContactChristopher Beck

Neuroradiologie

christopher.beck@uniklinik-freiburg.de076127051710

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026